Apollomics, Inc. (APLM)

G1 Therapeutics Revenue

In the year 2024, Apollomics had annual revenue of $198.00K, down -75.88%. Apollomics had revenue of $-1.57M in the half year ending December 31, 2024, with 477.21% growth.

• Revenue (ttm): $198.00K
• Revenue Growth: -75.88%
• P/S Ratio: 29.88
• Revenue / Employee: $15,231
• Employees: 13
• Market Cap: 6.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	198.00K	-623.00K	-75.88%
Dec 31, 2023	821.00K	498.00K	154.18%
Dec 31, 2022	323.00K	321.00K	16,050.00%
Dec 31, 2021	2.00K	-1.84M	-99.89%
Dec 31, 2020	1.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.